查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2069213

伴侶動物基因體學市場預測至2034年－按產品/服務、動物種類、技術、應用、最終用戶和地區分類的全球分析

Companion Animal Genomics Market Forecasts to 2034 - Global Analysis By Product And Service (Genetic Testing Kits, Instruments and Consumables, Software and Bioinformatics and Services), Animal Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球伴侶動物基因組學市場規模將達到 23 億美元，並在預測期內以 10.4% 的複合年成長率成長，到 2034 年將達到 51 億美元。

伴侶動物基因組學是指利用先進的基因測序和生物資訊技術，對包括犬、貓和其他家養寵物在內的伴侶動物的完整基因組進行研究和分析。這包括研究基因、遺傳變異和遺傳性狀，以了解健康傾向、疾病風險、品種特徵、祖先資訊和生物學功能。伴侶動物基因體學是精準獸醫學、育種最佳化、疾病預防、診斷方法開發、寵物個人化醫療策略的基礎。

遺傳疾病篩檢的需求

育種者、獸醫和寵物飼主對純種伴侶動物遺傳疾病的普遍性和經濟影響的認知不斷提高，推動了基因組篩檢計畫的普及。主要市場的犬舍俱樂部和品種協會已將提交遺傳健康證明作為註冊和繁殖許可的條件。面向大眾的基因檢測平台使人們能夠廣泛獲取品種血統和疾病易感性資訊。獸醫正在將繁殖前基因組檢測納入生殖健康諮詢。

獸醫學領域缺乏基因組分析的專業知識

缺乏接受臨床基因組學解讀正規訓練的獸醫專業人員，阻礙了基因組檢測結果在診斷和治療決策中的實際應用。許多執業獸醫表示，他們難以向客戶傳達遺傳風險觀察，也難以根據遺傳易感性數據制定治療方案。獸醫基因組學方面的繼續教育項目數量和範圍仍然有限。解讀多基因性狀的複雜性超出了一般獸醫在沒有專家支持的情況下進行分析的能力範圍。

個性化獸醫學的發展

個人化獸醫學作為一種臨床模式的興起，為伴侶動物基因組學在藥物基因組學、營養基因組學和精準治療方案製定等領域帶來了巨大的發展機會。藥物代謝途徑的基因組分析能夠幫助獸醫最佳化個別動物的藥物選擇和劑量，並減輕藥物副作用。營養基因組學檢測有助於推薦個人化飲食，是一項具有高成長潛力的商業性應用。將基因組數據與電子健康記錄（EHR）整合，可實現精準的長期照護管理。

資料隱私和倫理問題

對伴侶動物基因組數據的所有權、儲存和商業用途日益嚴格的審查，引發了寵物飼主和動物權益倡導團體的倫理和法律擔憂。關於主要用於診斷目的的基因數據（尤其是在研發領域）的二次利用是否合法，仍有疑問。在許多司法管轄區，伴侶動物基因組數據的監管框架落後於商業實踐。未經明確同意而共用資料的案例被公開，會損害消費者的信任，並為偵測公司帶來聲譽風險。

新型冠狀病毒（COVID-19）的影響：

新冠感染疾病初期，由於人員短缺和供應鏈中斷，伴侶動物基因組檢測機構的運作受到影響，定序試劑的供應也受到衝擊。但同時，疫情加速了全球寵物領養，顯著擴大了伴侶動物的數量及其潛在市場。疫情後，隨著數位醫療的普及和消費者對寵物綜合保健投入的增加，伴侶動物市場持續成長。此外，疫情也激發了人們對通用感染疾病傳播相關基因組研究的興趣，間接提高了伴侶動物基因組學的知名度和公眾認知度。

在預測期內，基因檢測套組細分市場預計將佔據最大的市場佔有率。

預計在預測期內，基因檢測套組細分市場將佔據最大的市場佔有率，這主要得益於直接面對消費者 (DTC) 和獸醫處方檢測平台的快速擴張，這些平台能夠便捷地提供品種、血統和疾病篩檢服務。消費者對檢體採樣便利性的需求正在推動電商和寵物零售通路的試劑盒銷售成長。具有競爭力的價格和簡化的檢體提交流程正在將目標用戶群體遠遠擴展到早期用戶之外。獸醫診所採用基因檢測套組計畫為專家推薦和重複購買提供了管道。可檢測疾病項目的持續擴展以及品種特異性試劑盒的日益普及預計將在整個預測期內維持該類別的成長。

在預測期內，次世代定序(NGS) 領域預計將呈現最高的複合年成長率。

在預測期內，受定序成本大幅下降、通量提升以及在伴侶動物疾病診斷、藥物基因體學和微生物組分析等領域臨床應用不斷擴展的推動，次世代定序（NGS）領域預計將呈現最高的成長率。隨著單樣本價格的降低，全基因組和全EXOME定序技術正從研究領域走向臨床獸醫實踐。學術和商業參考資料資料庫的擴充性提高了伴侶動物基因組變異解讀的準確性。將NGS數據與人工智慧驅動的臨床決策支援工具相結合，增強了診斷效用，並加速了其在專科獸醫診所和診斷實驗室網路中的應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其較高的伴侶動物飼養率、最先進的獸醫基因組學檢測設施基礎設施以及最高的直接面對消費者的基因檢測服務滲透率。美國擁有眾多領先的伴侶動物基因組學公司，這些公司推動全球市場銷售，其中包括 Embark Veterinary、Wisdom Panel 和 Mars Petcare 的基因平台。成熟的品種俱樂部基因健康認證計畫持續刺激著機構的檢測需求。強大的獸醫專家網路為先進的臨床基因組學應用建立了專業的分銷管道。學術研究機構和商業基因組學公司正在積極推進伴侶動物基因組資料庫的開發計畫。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本、韓國和澳洲寵物飼養量的快速成長，以及消費者對基因健康篩檢益處的日益重視。精通數位技術的中產階級寵物飼主群體不斷擴大，為面向消費者的基因檢測平台提供了有利的消費群。亞太地區的當地獸醫診所正在將基因組疾病篩檢作為差異化的加值服務。區域內對基因組研究基礎設施（包括政府資助的定序中心）的投資，正在提升本地的分析能力。亞太地區純種寵物飼養趨勢正在催生基因疾病認證計畫的結構性需求。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球伴侶動物基因體學市場：依產品與服務分類

  • 基因檢測套組
  • 設備和耗材
  • 軟體與生物資訊學
  • 服務

第6章：全球伴侶動物基因體學市場：依動物類型分類

  • 狗
  • 貓
  • 馬
  • 鳥類和異寵

第7章 全球伴侶動物基因體學市場：依技術分類

  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列
  • 次世代定序（NGS）
  • 桑格定序
  • 細胞遺傳學

第8章 全球伴侶動物基因體學市場：依應用分類

  • 育種管理
  • 遺傳疾病的鑑定
  • 個人化醫療
  • 法醫學與身份驗證
  • 血統和品種分析
  • 藥物基因體學

第9章：全球伴侶動物基因體學市場：依最終用戶分類

  • 獸醫醫院和診所
  • 診斷檢查室
  • 研究機構和大學
  • 繁殖者和犬種協會
  • 寵物飼主（DTC）

第10章：全球伴侶動物基因體學市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Zoetis Inc.
  • Mars, Incorporated
  • IdeCompanion Animal Genomics Laboratories, Inc.
  • Neogen Corporation
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen NV
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Embecta Corp.
  • Genetic Veterinary Sciences, Inc.
  • Basepaws, Inc.
  • Wisdom Panel
  • Embark Veterinary, Inc.
  • MyDogDNA
  • EasyDNA
  • Animal Genetics Inc.
Product Code: SMRC37230

According to Stratistics MRC, the Global Companion Animal Genomics Market is accounted for $2.3 billion in 2026 and is expected to reach $5.1 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Companion Animal Genomics refers to the study and analysis of the complete genetic makeup of companion animals, including dogs, cats, and other domesticated pets, using advanced genomic sequencing and bioinformatics technologies. It involves examining genes, genetic variations, and hereditary traits to understand health predispositions, disease risks, breed characteristics, ancestry, and biological functions. Companion animal genomics supports precision veterinary medicine, breeding optimization, disease prevention, diagnostic development, and personalized healthcare strategies for pets.

Market Dynamics:

Driver:

Hereditary disease screening demand

Growing awareness among breeders, veterinarians, and pet owners of the prevalence and economic impact of inherited genetic disorders in purebred companion animals is driving adoption of genomic screening programs. Kennel clubs and breed associations in major markets are mandating genetic health certifications as conditions of registration and breeding approval. Direct-to-consumer genetic testing platforms have democratized access to information about breed ancestry and disease predisposition. Veterinary practitioners are integrating pre-breeding genomic panels into reproductive health consultations.

Restraint:

Limited veterinary genomics expertise

The scarcity of veterinary professionals with formal training in clinical genomics interpretation constrains the translation of genomic test results into actionable diagnostic and therapeutic decisions. Many practicing veterinarians report uncertainty in communicating genetic risk findings to clients and in designing management protocols based on genetic predisposition data. Continuing education programs in veterinary genomics remain limited in availability and scope. The complexity of polygenic trait interpretation exceeds the analytical capacity of general practice settings without specialist support.

Opportunity:

Personalized veterinary medicine growth

The emergence of personalized veterinary medicine as a clinical paradigm creates substantial expansion opportunities for companion animal genomics across pharmacogenomics, nutritional genomics, and precision treatment planning. Genomic profiling of drug metabolism pathways enables veterinarians to optimize pharmaceutical selection and dosing for individual animals, reducing adverse drug reactions. Nutrigenomic testing informing personalized dietary recommendations represents a high-growth commercial application. Integration of genomic data with electronic health records enables longitudinal precision care management.

Threat:

Data privacy and ethics concerns

Increasing scrutiny of companion animal genomic data ownership, storage, and commercial use is raising ethical and legal concerns among pet owners and advocacy organizations. Questions persist about the permissible secondary use of genetic data collected for primary diagnostic purposes, particularly in research and product development contexts. Regulatory frameworks governing companion animal genomic data handling lag behind commercial practice in many jurisdictions. Publicized incidents of data sharing without explicit consent damage consumer trust and create reputational risks for testing companies.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted companion animal genomics laboratory operations through staffing restrictions and supply chain interruptions, affecting sequencing reagent availability. The pandemic simultaneously accelerated pet adoption globally, substantially enlarging the companion animal population and future addressable market. Post-pandemic, accelerated digital health adoption and increased consumer investment in comprehensive pet health management have sustained demand growth. The crisis also prompted scientific interest in zoonotic transmission genomics, indirectly elevating the profile and public awareness of companion animal genomic science.

The genetic testing kits segment is expected to be the largest during the forecast period

The genetic testing kits segment is expected to account for the largest market share during the forecast period, due to the rapid expansion of direct-to-consumer and veterinary-prescribed testing platforms offering accessible breed, ancestry, and disease screening panels. Consumer demand for at-home sample collection convenience drives kit volume across e-commerce and pet retail channels. Competitive pricing and simplified submission workflows have expanded the addressable population well beyond early adopter demographics. Veterinary practice integration of genetic kit programs provides professional endorsement and repeat purchase channels. Continuous expansion of detectable condition panels and species-specific kit offerings sustains category growth throughout the forecast period.

The next-generation sequencing (NGS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the next-generation sequencing (NGS) segment is predicted to witness the highest growth rate, driven by precipitously declining sequencing costs, improving throughput, and expanding clinical applications across companion animal disease diagnosis, pharmacogenomics, and microbiome analysis. Whole-genome and whole-exome sequencing approaches are transitioning from research to clinical veterinary settings as price-per-sample thresholds reach practitioner-accessible levels. Academic and commercial reference database expansion improves variant interpretation accuracy for companion animal genomes. Integration of NGS data with AI-driven clinical decision support tools enhances diagnostic utility and accelerates adoption in specialist veterinary practices and diagnostic laboratory networks.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the highest companion animal ownership rates, the most advanced veterinary genomics laboratory infrastructure, and the strongest consumer uptake of direct-to-consumer genetic testing services. The United States is home to leading companion animal genomics companies, including Embark Veterinary, Wisdom Panel, and Mars Petcare genetics platforms, which dominate global market revenue. Established kennel club genetic health certification programs generate recurring institutional testing demand. Strong veterinary specialist networks create professional channel distribution for advanced clinical genomic applications. Academic research institutions and commercial genomics companies maintain active companion animal genome database development programs.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding companion animal ownership across China, Japan, South Korea, and Australia, combined with increasing consumer awareness of genetic health screening benefits. Growing middle-class pet owner demographics with high digital engagement represent a receptive consumer base for direct-to-consumer genomic testing platforms. Local veterinary practices in Asia Pacific are adopting genomic disease screening as differentiated premium service offerings. Regional investments in genomic research infrastructure, including government-funded sequencing centers, are expanding local analytical capabilities. Rising purebred pet ownership trends in Asia Pacific create structural demand for hereditary disease certification programs.

Key players in the market

Some of the key players in Companion Animal Genomics Market include Zoetis Inc., Mars, Incorporated, IDEXX Laboratories, Inc., Neogen Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Embecta Corp., Genetic Veterinary Sciences, Inc., Basepaws, Inc., Wisdom Panel, Embark Veterinary, Inc., MyDogDNA, EasyDNA and Animal Genetics Inc.

Key Developments:

In May 2026, Embark Veterinary, Inc. launched a comprehensive whole-genome sequencing service for dogs providing over two hundred and thirty hereditary health condition screenings and a complete ancestry composition analysis through a direct-to-consumer platform update.

In April 2026, Illumina, Inc. introduced a companion animal-optimized sequencing workflow for veterinary diagnostic laboratories, reducing whole-genome turnaround time to forty-eight hours and lowering per-sample sequencing costs by thirty percent.

In March 2026, Basepaws, Inc. expanded its feline oral health genomic panel to include microbiome analysis alongside genetic disease screening, providing a combined genomic and microbial health profile for cats through a single at-home sample kit.

Products And Services Covered:

  • Genetic Testing Kits
  • Instruments and Consumables
  • Software and Bioinformatics
  • Services

Animal Types Covered:

  • Canine
  • Feline
  • Equine
  • Avian and Exotic Pets

Technologies Covered:

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Cytogenetics

Applications Covered:

  • Breeding Management
  • Genetic Disease Identification
  • Personalized Medicine
  • Forensics and Identification
  • Ancestry and Breed Analysis
  • Pharmacogenomics

End Users Covered:

  • Veterinary Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes and Universities
  • Breeders and Kennel Clubs
  • Pet Owners (DTC)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Genomics Market, By Product and Service

  • 5.1 Genetic Testing Kits
  • 5.2 Instruments and Consumables
  • 5.3 Software and Bioinformatics
  • 5.4 Services

6 Global Companion Animal Genomics Market, By Animal Type

  • 6.1 Canine
  • 6.2 Feline
  • 6.3 Equine
  • 6.4 Avian and Exotic Pets

7 Global Companion Animal Genomics Market, By Technology

  • 7.1 Polymerase Chain Reaction (PCR)
  • 7.2 Microarray
  • 7.3 Next-Generation Sequencing (NGS)
  • 7.4 Sanger Sequencing
  • 7.5 Cytogenetics

8 Global Companion Animal Genomics Market, By Application

  • 8.1 Breeding Management
  • 8.2 Genetic Disease Identification
  • 8.3 Personalized Medicine
  • 8.4 Forensics and Identification
  • 8.5 Ancestry and Breed Analysis
  • 8.6 Pharmacogenomics

9 Global Companion Animal Genomics Market, By End User

  • 9.1 Veterinary Hospitals and Clinics
  • 9.2 Diagnostic Laboratories
  • 9.3 Research Institutes and Universities
  • 9.4 Breeders and Kennel Clubs
  • 9.5 Pet Owners (DTC)

10 Global Companion Animal Genomics Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Zoetis Inc.
  • 13.2 Mars, Incorporated
  • 13.3 IdeCompanion Animal Genomics Laboratories, Inc.
  • 13.4 Neogen Corporation
  • 13.5 Thermo Fisher Scientific Inc.
  • 13.6 Illumina, Inc.
  • 13.7 Qiagen N.V.
  • 13.8 Agilent Technologies, Inc.
  • 13.9 Bio-Rad Laboratories, Inc.
  • 13.10 Embecta Corp.
  • 13.11 Genetic Veterinary Sciences, Inc.
  • 13.12 Basepaws, Inc.
  • 13.13 Wisdom Panel
  • 13.14 Embark Veterinary, Inc.
  • 13.15 MyDogDNA
  • 13.16 EasyDNA
  • 13.17 Animal Genetics Inc.

List of Tables

  • Table 1 Global Companion Animal Genomics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Companion Animal Genomics Market Outlook, By Product and Service (2023-2034) ($MN)
  • Table 3 Global Companion Animal Genomics Market Outlook, By Genetic Testing Kits (2023-2034) ($MN)
  • Table 4 Global Companion Animal Genomics Market Outlook, By Instruments and Consumables (2023-2034) ($MN)
  • Table 5 Global Companion Animal Genomics Market Outlook, By Software and Bioinformatics (2023-2034) ($MN)
  • Table 6 Global Companion Animal Genomics Market Outlook, By Services (2023-2034) ($MN)
  • Table 7 Global Companion Animal Genomics Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 8 Global Companion Animal Genomics Market Outlook, By Canine (2023-2034) ($MN)
  • Table 9 Global Companion Animal Genomics Market Outlook, By Feline (2023-2034) ($MN)
  • Table 10 Global Companion Animal Genomics Market Outlook, By Equine (2023-2034) ($MN)
  • Table 11 Global Companion Animal Genomics Market Outlook, By Avian and Exotic Pets (2023-2034) ($MN)
  • Table 12 Global Companion Animal Genomics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 13 Global Companion Animal Genomics Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 14 Global Companion Animal Genomics Market Outlook, By Microarray (2023-2034) ($MN)
  • Table 15 Global Companion Animal Genomics Market Outlook, By Next-Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 16 Global Companion Animal Genomics Market Outlook, By Sanger Sequencing (2023-2034) ($MN)
  • Table 17 Global Companion Animal Genomics Market Outlook, By Cytogenetics (2023-2034) ($MN)
  • Table 18 Global Companion Animal Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 19 Global Companion Animal Genomics Market Outlook, By Breeding Management (2023-2034) ($MN)
  • Table 20 Global Companion Animal Genomics Market Outlook, By Genetic Disease Identification (2023-2034) ($MN)
  • Table 21 Global Companion Animal Genomics Market Outlook, By Personalized Medicine (2023-2034) ($MN)
  • Table 22 Global Companion Animal Genomics Market Outlook, By Forensics and Identification (2023-2034) ($MN)
  • Table 23 Global Companion Animal Genomics Market Outlook, By Ancestry and Breed Analysis (2023-2034) ($MN)
  • Table 24 Global Companion Animal Genomics Market Outlook, By Pharmacogenomics (2023-2034) ($MN)
  • Table 25 Global Companion Animal Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 26 Global Companion Animal Genomics Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • Table 27 Global Companion Animal Genomics Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 28 Global Companion Animal Genomics Market Outlook, By Research Institutes and Universities (2023-2034) ($MN)
  • Table 29 Global Companion Animal Genomics Market Outlook, By Breeders and Kennel Clubs (2023-2034) ($MN)
  • Table 30 Global Companion Animal Genomics Market Outlook, By Pet Owners (DTC) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.